Elomaa I - Search Results

1

Three-year oral clodronate treatment does not impair mineralization of newly formed bone--a histomorphometric study.

Saarto T, Taube T, Blomqvist C, Vehmanen L, Elomaa I. Saarto T, et al. Among authors: elomaa i. Calcif Tissue Int. 2005 Aug;77(2):84-90. doi: 10.1007/s00223-004-0262-2. Epub 2005 Aug 11. Calcif Tissue Int. 2005. PMID: 16075363 Clinical Trial.

2

Short-term intermittent intravenous clodronate in the prevention of bone loss related to chemotherapy-induced ovarian failure.

Vehmanen L, Saarto T, Risteli J, Risteli L, Blomqvist C, Elomaa I. Vehmanen L, et al. Among authors: elomaa i. Breast Cancer Res Treat. 2004 Sep;87(2):181-8. doi: 10.1023/B:BREA.0000041624.00665.4e. Breast Cancer Res Treat. 2004. PMID: 15377842 Clinical Trial.

3

Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.

Vehmanen L, Elomaa I, Blomqvist C, Saarto T. Vehmanen L, et al. Among authors: elomaa i. J Clin Oncol. 2006 Feb 1;24(4):675-80. doi: 10.1200/JCO.2005.02.3515. J Clin Oncol. 2006. PMID: 16446340

4

Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer.

Saarto T, Vehmanen L, Blomqvist C, Elomaa I. Saarto T, et al. Among authors: elomaa i. J Clin Oncol. 2008 Sep 10;26(26):4289-95. doi: 10.1200/JCO.2007.15.4997. J Clin Oncol. 2008. PMID: 18779616 Clinical Trial.

5

The effect of ovarian dysfunction on bone mineral density in breast cancer patients 10 years after adjuvant chemotherapy.

Vehmanen LK, Elomaa I, Blomqvist CP, Saarto T. Vehmanen LK, et al. Among authors: elomaa i. Acta Oncol. 2014 Jan;53(1):75-9. doi: 10.3109/0284186X.2013.792992. Epub 2013 May 29. Acta Oncol. 2014. PMID: 23713891

6

Clodronate for osteolytic metastases due to breast cancer.

Elomaa I, Blomqvist C, Porkka L, Holmström T, Taube T, Lamberg-Allardt C, Borgström GH. Elomaa I, et al. Biomed Pharmacother. 1988;42(2):111-6. Biomed Pharmacother. 1988. PMID: 2971403 Clinical Trial.

7

Clodronate and other bisphosphonates as supportive therapy in osteolysis due to malignancy.

Elomaa I, Blomqvist C. Elomaa I, et al. Acta Oncol. 1995;34(5):629-36. doi: 10.3109/02841869509094039. Acta Oncol. 1995. PMID: 7546830 Review.

8

Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric study.

Taube T, Elomaa I, Blomqvist C, Beneton MN, Kanis JA. Taube T, et al. Among authors: elomaa i. Eur J Cancer. 1993;29A(12):1677-81. doi: 10.1016/0959-8049(93)90103-m. Eur J Cancer. 1993. PMID: 8398293 Clinical Trial.

9

Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer.

Saarto T, Blomqvist C, Ehnholm C, Taskinen MR, Elomaa I. Saarto T, et al. Among authors: elomaa i. J Clin Endocrinol Metab. 1996 Dec;81(12):4453-7. doi: 10.1210/jcem.81.12.8954058. J Clin Endocrinol Metab. 1996. PMID: 8954058

10

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.

Saarto T, Blomqvist C, Välimäki M, Mäkelä P, Sarna S, Elomaa I. Saarto T, et al. Among authors: elomaa i. Br J Cancer. 1997;75(4):602-5. doi: 10.1038/bjc.1997.105. Br J Cancer. 1997. PMID: 9052418 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters